Author name: R A

The fragment-based drug discovery market is estimated to be worth around USD 1.6 billion by 2030, predicts Roots Analysis

Health & Fitness / /

Screening small molecule fragments has made it possible to identify pharmacological leads against otherwise hard to target hotspots on biomolecules, such as allosteric sites, rendering this approach a valuable alternative method of drug discovery   Roots Analysis is pleased to announce the publication of its recent study, titled, “Fragment-based Drug Discovery Market: Library and Service […]

The fragment-based drug discovery market is estimated to be worth around USD 1.6 billion by 2030, predicts Roots Analysis Read More »

Fragment-based Drug Discovery Market: Library and Service Providers, 2020-2030

Health & Fitness / /

Traditional drug discovery is associated with exorbitant investments, prolonged lead evolution timelines and high attrition rates; the fragment-based approach is a versatile technique, enabling researchers to mitigate a number of existing challenges   London   Roots Analysis has announced the addition of the “Fragment-based Drug Discovery Market: Library and Service Providers, 2020-2030” report to its

Fragment-based Drug Discovery Market: Library and Service Providers, 2020-2030 Read More »

The “Next Generation Immune Checkpoint Inhibitors and Stimulators Market, 2020-2030” report features an extensive study of the current market landscape

Health & Fitness / /

To order this detailed 350+ page report, please visit this link   Key Inclusions A detailed assessment of the current market landscape, including information on drug developer(s), phase of development (marketed, clinical and preclinical / discovery stage) of lead candidates, target immune checkpoints, their respective mechanisms of action (inhibitory or stimulatory),  type of therapeutic modality

The “Next Generation Immune Checkpoint Inhibitors and Stimulators Market, 2020-2030” report features an extensive study of the current market landscape Read More »

More than 150 industry players across the world are presently engaged in evaluating the potential of nearly 300 next generation

Health & Fitness / /

Over time, significant strides have been made in immune checkpoint research, resulting in the discovery of several inhibitory (LAG-3, TIM-3, TIGIT, VISTA and B7-H3) and stimulatory receptors (OX40, ICOS, GITR, 4-1BB and CD40), which are being investigated as potential targets for therapy development. Further, studies of combinatorial immune checkpoint blockade / co-stimulation, targeting newly identified

More than 150 industry players across the world are presently engaged in evaluating the potential of nearly 300 next generation Read More »

The next generation immune checkpoint inhibitors and stimulators market is projected to grow at an annualized rate of 15%

Health & Fitness / /

has done a detailed study on Next Generation Immune Checkpoint Inhibitors and Stimulators Market, 2020-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.   To order this 350+ page report, which features 140+ figures and 170+ tables, please visit this link   Key Market Insights More than 150 industry players

The next generation immune checkpoint inhibitors and stimulators market is projected to grow at an annualized rate of 15% Read More »

The next generation immune checkpoint inhibitors and stimulators market is estimated to be worth USD 12.5 billion in 2030

Health & Fitness / /

Therapies targeting novel inhibitory and stimulatory immune checkpoints have been shown to possess substantial therapeutic potential, both as monotherapies and in combination with other interventions, across multiple disease interventions   is pleased to announce the publication of its recent study, titled, “Next Generation Immune Checkpoint Inhibitors and Stimulators Market, 2020-2030.”   The report features an

The next generation immune checkpoint inhibitors and stimulators market is estimated to be worth USD 12.5 billion in 2030 Read More »

Next Generation Immune Checkpoint Inhibitors and Stimulators Market, 2020-2030

Health & Fitness / /

The success of CTLA4, PD-1, and PD-L1 inhibitors paved the way for researchers to explore the vast therapeutic potential of immune checkpoint modulation, enabling the discovery of product candidates against clinical conditions beyond oncology   Roots Analysis has announced the addition of “Next Generation Immune Checkpoint Inhibitors and Stimulators Market, 2020-2030” report to its list

Next Generation Immune Checkpoint Inhibitors and Stimulators Market, 2020-2030 Read More »